IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 77.853
EU - Europa 43.639
AS - Asia 41.677
SA - Sud America 9.211
AF - Africa 1.061
Continente sconosciuto - Info sul continente non disponibili 160
OC - Oceania 83
Totale 173.684
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 73.838
SG - Singapore 15.082
RU - Federazione Russa 10.952
CN - Cina 10.370
IT - Italia 9.561
GB - Regno Unito 8.432
BR - Brasile 7.155
VN - Vietnam 6.012
DE - Germania 3.000
HK - Hong Kong 2.970
CA - Canada 2.809
BD - Bangladesh 2.693
UA - Ucraina 2.666
FR - Francia 1.621
DK - Danimarca 1.587
SE - Svezia 1.416
FI - Finlandia 1.106
IN - India 915
MX - Messico 764
IE - Irlanda 763
AR - Argentina 717
PL - Polonia 712
NL - Olanda 550
TR - Turchia 510
ID - Indonesia 435
IL - Israele 411
EC - Ecuador 372
ZA - Sudafrica 368
ES - Italia 352
JP - Giappone 338
IQ - Iraq 337
PK - Pakistan 296
CO - Colombia 250
AT - Austria 201
VE - Venezuela 193
MA - Marocco 174
UZ - Uzbekistan 159
CL - Cile 150
EU - Europa 149
AE - Emirati Arabi Uniti 137
LT - Lituania 130
SA - Arabia Saudita 130
PY - Paraguay 129
MY - Malesia 105
EG - Egitto 104
PE - Perù 97
PH - Filippine 96
KE - Kenya 91
TN - Tunisia 84
KR - Corea 77
JM - Giamaica 71
UY - Uruguay 71
DZ - Algeria 69
JO - Giordania 68
CR - Costa Rica 67
CH - Svizzera 62
BO - Bolivia 60
IR - Iran 60
BE - Belgio 59
NP - Nepal 54
AU - Australia 53
HN - Honduras 53
SK - Slovacchia (Repubblica Slovacca) 53
AZ - Azerbaigian 48
RO - Romania 46
PT - Portogallo 45
CZ - Repubblica Ceca 41
AL - Albania 40
DO - Repubblica Dominicana 40
KZ - Kazakistan 39
GT - Guatemala 37
TW - Taiwan 35
ET - Etiopia 33
NI - Nicaragua 32
OM - Oman 32
TH - Thailandia 31
TT - Trinidad e Tobago 30
HU - Ungheria 27
KG - Kirghizistan 27
GR - Grecia 26
PA - Panama 24
SV - El Salvador 24
AM - Armenia 23
LB - Libano 23
PS - Palestinian Territory 22
RS - Serbia 22
CI - Costa d'Avorio 21
SN - Senegal 21
GE - Georgia 20
KW - Kuwait 19
NO - Norvegia 19
NZ - Nuova Zelanda 19
SI - Slovenia 18
BB - Barbados 17
LV - Lettonia 17
BG - Bulgaria 16
BH - Bahrain 16
QA - Qatar 16
MD - Moldavia 15
NG - Nigeria 14
Totale 173.361
Salva come PNG Salva come JPEG
Città #
Dallas 13.960
Singapore 7.643
Southend 5.518
San Jose 4.944
Ashburn 4.873
Beijing 4.073
Woodbridge 2.871
Hong Kong 2.708
Chandler 2.556
Ann Arbor 2.547
Houston 2.378
Los Angeles 2.223
Moscow 1.997
Fairfield 1.914
Chicago 1.867
San Mateo 1.857
Ho Chi Minh City 1.733
Milan 1.601
Falls Church 1.553
Seattle 1.346
Dearborn 1.328
New York 1.241
Jacksonville 1.219
The Dalles 1.181
Wilmington 1.162
Cambridge 1.160
Hanoi 1.083
Rome 1.007
Ottawa 955
Buffalo 900
Council Bluffs 894
Santa Clara 861
Hefei 807
Lauterbourg 798
São Paulo 762
Salt Lake City 760
Boardman 748
Dublin 742
Stevenage 685
Portsmouth 683
Pisa 656
Warsaw 643
Dong Ket 641
Helsinki 555
Lawrence 525
Brooklyn 467
Beauharnois 444
Orem 438
Tampa 431
Munich 415
Montréal 406
Montreal 380
London 376
Elk Grove Village 363
Tel Aviv 356
Mexico City 348
Frankfurt am Main 298
Florence 291
Tokyo 288
Denver 272
Chennai 267
Columbus 265
Rio de Janeiro 251
Atlanta 246
Johannesburg 235
Stockholm 235
Istanbul 231
Phoenix 231
Toronto 230
Amsterdam 227
San Diego 227
Poplar 223
Figino 219
Da Nang 211
Haiphong 198
Nuremberg 194
Boston 172
Turin 171
Sterling 165
Miami 161
Naples 161
Redwood City 161
Lancaster 158
Old Bridge 158
Bologna 156
Belo Horizonte 146
Tashkent 144
San Francisco 143
Brasília 139
Manchester 136
Guangzhou 133
Lappeenranta 132
Guayaquil 127
Biên Hòa 123
Ankara 120
Curitiba 119
Mumbai 118
Washington 117
Central District 114
Turku 113
Totale 104.808
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.845
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.706
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.581
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.362
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 893
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 732
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 618
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 606
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 511
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 506
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 489
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 485
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 453
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 446
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 437
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 423
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 410
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 399
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 397
A simple echocardiographic score to rule out cardiac amyloidosis 390
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 384
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 383
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 380
Cartella clinica automatizzata per il reparto di cardiologia 376
An Open System for Managing Long Term ECG Recordings 372
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 371
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 365
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 362
Building medical knowledge from real world registries: The case of heart failure 361
A simple echocardiographic score to rule out cardiac amyloidosis 360
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 358
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 357
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 351
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 347
Central sleep apnea and cardiovascular disease state-of-the-art 344
La neuropatia diabetica 342
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 342
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 338
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 337
[Central apneas and cardiovascular diseases] 337
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 334
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 334
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 333
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 332
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 332
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 331
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 331
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 330
Prediction of the chemoreflex gain by common clinical variables in heart failure 330
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 329
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 328
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 328
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 327
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 326
Treating chemoreflex in heart failure: modulation or demolition? 326
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 326
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 323
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 320
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 320
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 317
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 317
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 316
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 315
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 315
Etiology, clinical presentation, and management of left main coronary artery aneurysms 314
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 314
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 313
Adrenergic activation in heart failure: blockade or rebalance? 313
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 311
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 309
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 309
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 308
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 306
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 305
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 305
Effects of smoking in patients treated with cardiac resynchronization therapy 305
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 304
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 304
Eligibility for vericiguat in a real‐world, contemporary heart failure population 303
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 303
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 302
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 302
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 302
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 301
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 301
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 300
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 300
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 299
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 298
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 297
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 297
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 296
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 296
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 295
[Ten perspectives for research and innovation in cardiac amyloidosis] 294
Screening the health status of people working in a university 294
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 294
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 293
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 293
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 293
Totale 40.549
Salva come PNG Salva come JPEG
Categoria #
all - tutte 853.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 853.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.921 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.958
2025/202686.267 4.297 13.612 10.203 10.763 8.532 5.113 8.848 3.768 5.099 5.501 5.107 5.424
2026/20271.501 1.501 0 0 0 0 0 0 0 0 0 0 0
Totale 174.734